Free Trial

Target Healthcare REIT (THRL) Competitors

Target Healthcare REIT logo
GBX 100.60 +1.20 (+1.21%)
As of 03:58 AM Eastern

THRL vs. AGR, PHP, IHR, LABS, MXF, IWG, DLN, SRE, GPOR, and BYG

Should you be buying Target Healthcare REIT stock or one of its competitors? The main competitors of Target Healthcare REIT include Assura (AGR), Primary Health Properties (PHP), Impact Healthcare REIT (IHR), Life Science REIT (LABS), Medicx Fund (MXF), IWG (IWG), Derwent London (DLN), Sirius Real Estate (SRE), Great Portland Estates (GPOR), and Big Yellow Group (BYG). These companies are all part of the "real estate" sector.

Target Healthcare REIT vs. Its Competitors

Assura (LON:AGR) and Target Healthcare REIT (LON:THRL) are both small-cap real estate companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, institutional ownership, risk, media sentiment and dividends.

In the previous week, Assura had 1 more articles in the media than Target Healthcare REIT. MarketBeat recorded 1 mentions for Assura and 0 mentions for Target Healthcare REIT. Assura's average media sentiment score of 0.63 beat Target Healthcare REIT's score of 0.00 indicating that Assura is being referred to more favorably in the media.

Company Overall Sentiment
Assura Positive
Target Healthcare REIT Neutral

Target Healthcare REIT has lower revenue, but higher earnings than Assura. Assura is trading at a lower price-to-earnings ratio than Target Healthcare REIT, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Assura£188.76M8.49-£34.15M-£1.05-47.01
Target Healthcare REIT£68.64M8.97£72.07M£11.938.43

Assura has a beta of 0.37, suggesting that its share price is 63% less volatile than the S&P 500. Comparatively, Target Healthcare REIT has a beta of 0.44, suggesting that its share price is 56% less volatile than the S&P 500.

73.7% of Assura shares are owned by institutional investors. Comparatively, 69.4% of Target Healthcare REIT shares are owned by institutional investors. 8.4% of Assura shares are owned by company insiders. Comparatively, 0.1% of Target Healthcare REIT shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Target Healthcare REIT has a net margin of 104.99% compared to Assura's net margin of -18.09%. Target Healthcare REIT's return on equity of 10.78% beat Assura's return on equity.

Company Net Margins Return on Equity Return on Assets
Assura-18.09% -1.92% 2.82%
Target Healthcare REIT 104.99%10.78%3.86%

Assura currently has a consensus price target of GBX 51, indicating a potential upside of 3.70%. Given Assura's stronger consensus rating and higher probable upside, research analysts plainly believe Assura is more favorable than Target Healthcare REIT.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Assura
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
Target Healthcare REIT
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Assura pays an annual dividend of GBX 3 per share and has a dividend yield of 6.1%. Target Healthcare REIT pays an annual dividend of GBX 6 per share and has a dividend yield of 6.0%. Assura pays out -286.8% of its earnings in the form of a dividend. Target Healthcare REIT pays out 50.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Assura is clearly the better dividend stock, given its higher yield and lower payout ratio.

Summary

Assura beats Target Healthcare REIT on 10 of the 18 factors compared between the two stocks.

Get Target Healthcare REIT News Delivered to You Automatically

Sign up to receive the latest news and ratings for THRL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding THRL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

THRL vs. The Competition

MetricTarget Healthcare REITREIT IndustryReal Estate SectorLON Exchange
Market Cap£615.78M£1.62B£1.61B£3.07B
Dividend Yield7.00%7.52%6.26%5.02%
P/E Ratio8.431.4010.68168.22
Price / Sales8.97524.591,201.30339,980.05
Price / Cash14.3749.2266.7927.97
Price / Book0.911.411.334.55
Net Income£72.07M-£74.43M-£120.13M£5.90B
7 Day Performance1.31%-0.30%0.06%1.03%
1 Month Performance-0.40%-1.71%-0.47%12.14%
1 Year Performance25.75%14.33%9.75%73.00%

Target Healthcare REIT Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
THRL
Target Healthcare REIT
N/AGBX 100.60
+1.2%
N/A+27.8%£615.78M£68.64M8.43N/A
AGR
Assura
1.3912 of 5 stars
GBX 49.94
+0.1%
GBX 51
+2.1%
+18.7%£1.63B£188.76M-47.7484
PHP
Primary Health Properties
2.8228 of 5 stars
GBX 95.90
-0.1%
GBX 107.50
+12.1%
+3.6%£1.29B£178.59M-149.7058Trending News
Insider Trade
IHR
Impact Healthcare REIT
N/AN/AN/AN/A£361.75M£53.51M793.64N/A
LABS
Life Science REIT
1.2707 of 5 stars
GBX 40.10
-0.2%
GBX 46.50
+16.0%
+13.7%£142.37M£20.41M-3.56N/A
MXF
Medicx Fund
N/AN/AN/AN/A£0.00N/A0.00N/AHigh Trading Volume
IWG
IWG
1.1191 of 5 stars
GBX 221.20
+0.7%
GBX 270
+22.1%
+40.8%£2.22B£2.76B-16.4510,000
DLN
Derwent London
2.0975 of 5 stars
GBX 1,934
+1.2%
GBX 2,700
+39.6%
-14.4%£2.17B£277.67M-6.00199
SRE
Sirius Real Estate
3.2141 of 5 stars
GBX 105
+0.4%
GBX 117.50
+11.9%
+11.5%£1.90B£386.21M13.74241Positive News
GPOR
Great Portland Estates
N/AN/AN/AN/A£1.87B£100.70M124.66210Gap Up
BYG
Big Yellow Group
3.792 of 5 stars
GBX 949
+0.9%
N/A-19.0%£1.85B£200.54M7.69503Positive News
Dividend Announcement
High Trading Volume

Related Companies and Tools


This page (LON:THRL) was last updated on 8/6/2025 by MarketBeat.com Staff
From Our Partners